11 More importantly, there was a nonsignificant trend suggesting that more infants with prolonged feed intolerance developed PNAC in the placebo group than in the oral erythromycin group. 11 However, there has been much controversy concerning the use of oral/intravenous erythromycin in promoting enteral feeding in preterm infants.
← all excerpts
High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
1
—
—